Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-(1-7) for severe COVID-19
RBR-35734pPhase 2Recruiting
- Sponsor
- Angitec
- Start
- Aug 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of angiotensin-(1-7) in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Angitec. Started Aug 2020; status: recruiting.
02
Drugs
angiotensin-(1-7)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-35734p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-35734p.